Login to Your Account

Amgen Offers To Buy Out Abgenix For $2.2B In Cash

By Karen Pihl-Carey and Randall Osborne

Thursday, December 15, 2005
In what could become one of the top acquisitions of 2005, Amgen Inc. offered to acquire Abgenix Inc. for $22.50 a share - or about $2.2 billion in cash. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription